At a glance
ClinicalIndex Comparison RecordN/ACompleted· 39 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Metabolomic Profiling of Urine Samples for the Identification of Novel Biomarkers and Mechanisms in the Diagnosis and Management of Malodor Associated With Metabolic Inefficiencies
In Brief
An observational study for Nutritional and Metabolic Diseases. Completed, enrolled 39 participants across 2 sites in 2 countries.
Detailed Summary
The purpose of this study is to identify metabolic signatures associated with malodor conditions. The investigators will perform state-of-the art metabolomics tests and bioinformatic data mining to explore if conditions leading to malodor can be screened by metabolomic profiling of urine samples.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNutritional and Metabolic Diseases
CountriesCanada, United States
CollaboratorsUniversity of Alberta
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedFeb 2016
Primary CompletionAug 2017
Study CompletionMay 2018
TodayJul 2026
First PostedFeb 17, 2016
Enrollment StartFeb 1, 2016
Primary CompletionAug 30, 2017
Study CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.4 years ago